Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing

March 27, 2025
Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership. This backing has provided Pfizer with a solid foundation and further increased investor confidence in their potential growth. Despite the challenges faced by the global healthcare industry, Pfizer continues to thrive and expand its market presence. In light of this, experts from Stocks Prognosis recommend considering investing in Pfizer stocks, as the company's strong institutional backing suggests a positive forecast for their future performance.

Find out how the PFIZER INC. rate is expected to change

Get Forecast for PFE

Investor opinions & comments:

I trust Pfizer's track record in the pharmaceutical industry, and with such a significant ownership by institutional investors, it's clear that others have confidence in their growth potential as well
— from InvestorTom at 03-30-2025 21:09
Pfizer's strong institutional support is a testament to their reputation and capabilities. I believe investing in their stocks will yield fruitful returns in the long run
— from TraderTara at 03-30-2025 05:39
I'm not so sure about investing in Pfizer. The healthcare industry is facing a lot of challenges, and I'm not convinced that Pfizer will be able to overcome them
— from DividendDiane at 03-29-2025 05:48
This is great news for Pfizer! With such strong institutional support, it's definitely worth considering investing in their stocks
— from DavidWilson at 03-28-2025 15:39
I'm hesitant to invest in Pfizer at the moment. The pharmaceutical industry is highly regulated, and there's always a risk of unexpected legal or regulatory issues affecting the company's operations
— from TylerGonzalez at 03-28-2025 13:38
¡Me parece una excelente oportunidad de inversión! Con el respaldo de instituciones sólidas, Pfizer promete un crecimiento sólido y estable en el futuro
— from AvaTurner at 03-28-2025 12:00
Pfizer has a strong presence in the market, and their institutional backing further solidifies their position. I have faith in their ability to navigate challenges and deliver positive results
— from SavvySusan at 03-28-2025 09:55
I think it's risky to invest in Pfizer considering the current global healthcare situation. We don't know how long this pandemic will last and how it will impact the company's performance
— from SavannahGordon at 03-28-2025 07:20
If you want to leave a comment, then you need Login or Register





Other news for PFE

PFEMarch 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch  ~1 min.

According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....

PFEMarch 20, 2025Pfizer Inc. PFE: Pioneering a New Era in Healthcare Innovation  ~2 min.

Pfizer Inc., a renowned pharmaceutical company, continues to revolutionize the healthcare industry with its groundbreaking innovations....

PFEMarch 19, 2025Is Pfizer Inc. PFE the Best Pharma Stock to Buy According to Hedge Funds  ~1 min.

Pfizer Inc. (PFE) has become a subject of interest for investors and hedge funds in the pharmaceutical industry....

PFEMarch 16, 2025Pfizer Inc. PFE Shows Promising Results in Collaboration with Arvinas  ~2 min.

Pfizer Inc. (PFE), one of the leading pharmaceutical companies, recently announced the positive topline results from its collaboration with Arvinas....

PFEMarch 1, 2025ING Groep NV Purchases 331403 Shares of Pfizer Inc. NYSE:PFE  ~1 min.

Investment firm ING Groep NV has recently acquired a significant number of shares in Pfizer Inc., a leading global pharmaceutical company....



Related news

CSCODecember 13, 2024Billionaire Asness Sold Cisco Systems CSCO and Bought Eli Lilly and Company LLY  ~2 min.

Cisco Systems Inc. (NASDAQ: CSCO) recently witnessed a significant change in its stock ownership as billionaire investor Cliff Asness sold his shares in the company....

LLYOctober 29, 2024LLY: Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval  ~2 min.

Eli Lilly and Company (NYSE:LLY) has recently received approval for its groundbreaking blockbuster drug, marking a significant milestone for the company....

AZNDecember 13, 2024Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000....

ABBVNovember 30, 2024ABBVIE INC.: A Leading Pharmaceutical Company with Strong Dividend Potential  ~2 min.

AbbVie Inc., a renowned pharmaceutical company, is attracting attention from investors due to its excellent dividend potential and strong market presence....

ABBVDecember 4, 2024ABBVIE INC.: A Leading Pharmaceutical Company with High Institutional Ownership  ~2 min.

AbbVie Inc. (NYSE: ABBV) is gaining attention in the investment world due to its high institutional ownership....